BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:37 PM
 | 
Jul 24, 2009
 |  BC Extra  |  Company News

FDA posts CorVue briefing documents

FDA posted briefing documents ahead of Tuesday's panel meeting to discuss an NDA from King Pharmaceuticals Inc. (NYSE:KG) for CorVue binodenoson as an adjunct to myocardial perfusion imaging (MPI) for detecting perfusion abnormalities in patients with known or suspected coronary artery disease (CAD). The agency will...

Read the full 219 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >